Early clinical development of a novel anti-angiogenic monoclonal antibody directed against A5B1 integrin for treatment of solid tumors

被引：0
|
作者：
Finck, BK [1 ]
机构：
[1] Prot Design Labs, Fremont, CA USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [31] Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors
    Sharifi, J
    Khawli, LA
    Hu, P
    King, S
    Epstein, AL
    HYBRIDOMA AND HYBRIDOMICS, 2001, 20 (5-6): : 305 - 312
  • [32] Interim results of phase I dose escalation study of YBL-006: A novel anti-PD-1 monoclonal antibody in advanced solid tumors
    Lee, K-W.
    Park, J.
    Oh, D-Y.
    Kim, S. H.
    Sabanathan, D.
    Kim, T. M.
    Kim, M.
    Yoon, J.
    Lee, H.
    Park, S.
    Paeng, K.
    Ock, C-Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S838 - S838
  • [33] DIFFERENTIAL-EFFECTS OF ANTI-B7-1 AND ANTI-B7-2 MONOCLONAL-ANTIBODY TREATMENT ON THE DEVELOPMENT OF DIABETES IN THE NONOBESE DIABETIC MOUSE
    LENSCHOW, DJ
    HO, SC
    SATTAR, H
    RHEE, L
    GRAY, G
    NABAVI, N
    HEROLD, KC
    BLUESTONE, JA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03): : 1145 - 1155
  • [34] Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas
    Kudo, Yuma
    Suzuki, Hiroyuki
    Tanaka, Tomohiro
    Kaneko, Mika K.
    Kato, Yukinari
    ANTIBODIES, 2023, 12 (02)
  • [35] Monoclonal antibody against VEGFR1 inhibits flt1-positive DU4475 human breast tumor growth by a dual mechanism involving anti-angiogenic and tumor cell growth inhibitory activities.
    Wu, Y
    Costa, C
    Hooper, A
    Kotanides, H
    Pytowiski, B
    Witte, L
    Hicklin, DJ
    Bohlen, P
    Rafii, S
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3654S - 3654S
  • [36] A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors
    Ankur Sharma
    Rupali A Gadkari
    Satthenapalli V Ramakanth
    Krishnanand Padmanabhan
    Davanam S Madhumathi
    Lakshmi Devi
    Lingappa Appaji
    Jon C Aster
    Annapoorni Rangarajan
    Rajan R Dighe
    Scientific Reports, 5
  • [37] A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors
    Sharma, Ankur
    Gadkari, Rupali A.
    Ramakanth, Satthenapalli V.
    Padmanabhan, Krishnanand
    Madhumathi, Davanam S.
    Devi, Lakshmi
    Appaji, Lingappa
    Aster, Jon C.
    Rangarajan, Annapoorni
    Dighe, Rajan R.
    SCIENTIFIC REPORTS, 2015, 5
  • [38] PHASE 1/2A STUDY OF THE NOVEL NONFUCOSYLATED ANTI-CTLA-4 MONOCLONAL ANTIBODY BMS-986218 ± NIVOLUMAB IN ADVANCED SOLID TUMORS: PART 1 RESULTS
    Friedman, Claire
    Carvajal, Richard
    Davar, Diwakar
    Castanon, Eduardo
    Ascierto, Paolo
    Calvo, Emiliano
    O'Hara, Mark
    Powell, Steven
    Shapira-Frommer, Ronnie
    Garralda, Elena
    Renouf, Daniel John
    Perets, Ruth
    Yunan, Mona
    Ravindran, Palanikumar
    Hammell, Amy
    O'Brien, Shaun
    Xu, Ke
    Wilson, Nicholas
    Jhatakia, Amy
    Mukhopadhyay, Anandaroop
    Gutierrez, Martin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A620 - A621
  • [39] Early Clinical Development of GNBAC1 a Humanized Monoclonal Antibody Neutralizing MSRV-ENV, a Neurotoxic Protein, for the Treatment of Multiple Sclerosis
    Peter, Hartung Hans
    Perron, Herve
    Lang, Alois
    Porchet, Herve
    Curtin, Francois
    NEUROLOGY, 2016, 86
  • [40] Pre-clinical development of a dopamine receptor 2, PD-1, and CD47 trispecific antibody for the treatment of solid tumors
    Yao, Shugang
    Zahreddine, Hiba
    Hou, Dominic
    Undzys, Elijus
    Gong, Liying
    Wargachuk, Richard
    Wang, Xiaowei
    Zhou, Alex
    Lai, Lucy
    Da Cruz, Luis A.
    Young, David
    CANCER RESEARCH, 2023, 83 (07)
12345